Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and ...

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my post earnings update for NVAX stock.

Novavax takes the RNA sequence that codes ... vaccine that covers the needs of the space as it is now. The vaccine is approved in over 40 countries and recommended by the WHO.

Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...

The Novavax's COVID vaccine was approved by the US Food and Drug Administration for people age 12 and older in August 2024. This places it alongside Moderna's and Pfizer-BioNTech's refreshed formulas.

These awards were approved by the Compensation C Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will ...

Novavax is also progressing well with its preclinical pipeline, which includes vaccines for RSV and H5N1 ... If this filing is approved, it will trigger a $175 million milestone payment from ...

As per DelveInsight estimates, North America is anticipated to dominate the global influenza vaccine market during the forecast period. In the type segment of the influenza vaccine market, the ...

The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in older ...

Novavax has said it intends to file for ... The UK government has ordered 60 million doses of the protein subunit vaccine, and if approved by the Medicines and Healthcare products Regulatory ...

Mahesh Kumar, senior vice president of global biopharmaceutical research and development at Zoetis, noted, "The vaccine that the USDA has conditionally approved this time is the one we are ...